Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$183,435,241
-$8,956,629 QoQ
Shares Held
728,959
-17.6% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#171
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SEI INVESTMENTS CO holds $2,466,204,715 across 17 Drug Manufacturers - General names. ABBV ranks #4 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
689,850 | $827,426,853 | |
| 2 | JNJ |
Johnson & Johnson
|
1,608,573 | $408,529,284 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,713,402 | $220,172,157 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
728,959 | $183,435,241 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,034,568 | $130,707,319 | |
| 6 | AMGN |
Amgen Inc
|
343,610 | $124,428,052 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,153,285 | $124,072,280 | |
| 8 | AZN |
Astrazeneca PLC
|
572,746 | $108,604,096 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $183,435,241 | 728,959 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $192,391,870 | 884,601 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $187,168,953 | 819,156 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $195,930,999 | 846,208 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $127,846,144 | 688,752 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $123,959,992 | 591,638 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $74,062,871 | 416,786 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $83,137,499 | 420,992 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $83,063,533 | 484,279 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $79,314,928 | 435,557 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $72,066,937 | 465,038 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $65,585,802 | 439,996 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $57,650,965 | 427,900 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $75,842,429 | 475,889 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $73,668,624 | 455,842 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $64,140,568 | 477,912 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $80,847,802 | 527,865 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $79,091,522 | 487,888 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $70,245,925 | 518,803 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $53,465,333 | 495,646 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $80,440,390 | 714,137 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $49,925,131 | 461,330 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $48,484,302 | 452,490 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $41,010,074 | 468,205 | Shares | Defined | 2020-12-04 | |
| 2020-06-30 | $57,028,539 | 580,857 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $40,119,748 | 526,575 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||